Immucell Corp. (ICCC)

NASDAQ

$10.46

$-0.31

(-2.90%)

Pre-Market

Immucell Corp. (ICCC) Live Price Chart

Last updated: ⁦2026-10-21 09:29:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Immucell Corp. (ICCC) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $10.46, with a market capitalization of $95.45M and a P/E ratio of 120.54. Over the past 52 weeks, its price has ranged from $4.52 to $12.10. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$95.45M
Open	$10.77
Day's High	$25.55
Day's Low	$1.33
Previous Close	$10.51
Volume	3.95K
Average Volume	19.43K
P/E Ratio	120.54
52-Week High	$12.10
52-Week Low	$4.52
Dividend Yield	--
Earnings Date	--

Immucell Corp. (ICCC) Pre-Market Stock Price

Immucell Corp. (ICCC) is trading at $10.43 in pre-market trading as of 2026-10-20 23:31:00, down 0.77% ($0.08) from the previous close of $10.51

Pre-market trading shows how investors are pricing ICCC before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Immucell Corp. (ICCC) 7-Day Stock Price Change

Over the past seven days, Immucell Corp. (ICCC) moved from $9.60 to $10.46, representing a gain of 8.96% ($0.86).

The stock traded between $9.60 and $10.89 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 13.61 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

ICCC 52-Week Price Position

Position in Range: 78.4%

52W Low$4.52

52W High$12.10

ICCC is currently trading at $10.46, placing it 78.4% of the way from its 52-week low of $4.52 to its 52-week high of $12.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Immucell Corp. (ICCC)?

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Immucell Corp. Information

Industry	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees	73
Exchange	NASDAQ
Company Website	https://www.immucell.com

How to Buy Immucell Corp. (ICCC) Stock on MEXC

Eligible investors can buy real shares of Immucell Corp. (ICCC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ICCC and Place Your Order

Open the RealStocks trading page and search for ICCC. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Immucell Corp. (ICCC) stock price today?

Immucell Corp. (ICCC) is currently trading at $ 10.46, down 0.48% ($0.05) from the previous close of $ 10.51. Intraday prices update in real time during regular trading hours.

2.Is ICCC stock going up or down today?

As of 2026-10-20 23:31:00, ICCC is trading at $ 10.46, down 0.48% ($0.05) from its previous close of $ 10.51. The stock has traded between $ 1.33 and $ 25.55 during today’s regular session. Past price movements do not guarantee future results.

3.What is ICCC pre-market price?

As of 2026-10-20 23:31:00, ICCC is trading at $ 10.43 in pre-market trading, down 0.77% ($0.08) from the previous close of $ 10.51. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ICCC after-hours price?

As of 2026-10-20 23:31:00, ICCC is trading at $ 10.43 in after-hours trading, down 0.81% ($0.08) from the regular-session close of $ 10.51. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ICCC stock trading now?

ICCC trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ICCC sit relative to its 52-week high and low?

Over the past 52 weeks, ICCC has traded between a low of $ 4.52 and a high of $ 12.10. At $ 10.46, the stock is positioned 78.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Immucell Corp. in?

Immucell Corp. (ICCC) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Immucell Corp.'s market capitalization and where is it listed?

Immucell Corp. is listed on the NASDAQ exchange with a market capitalization of $ 95.45M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ICCC valued in terms of P/E ratio and EPS?

ICCC trades at a P/E ratio of 120.54, based on trailing-twelve-month EPS of $ 0.09. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Immucell Corp. pay a dividend?

Immucell Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.